Foundation Medicine, Inc. FMI
137.00 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
137.00 Day range 137.00
136.75 52-week range 137.00
News
gurufocus.com Is Fastenal Co (FAST) Overvalued After Q3 Earnings Beat? EPS at $0.35 vs Estimated $0.34, Revenue at $2.463 Billion vs Estimated $2.440 Billion -- GF Score: 95/100 Fastenal Co (FAST) released its 8-K filing on October 14, 2026, revealing robust performance figures for the third quarter ended September 30, 2026. The company
gurufocus.com Fastenal Co (FAST) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Pricing Challenges Daily Sales Growth: 12.4% increase to $34.9 million per day.Operating Margin: Improved to 20.3%, up 20 basis points from last year.Digital Sales: Digital chann
prnewswire.com Spirit Announces Sale of Fiber Materials Inc. (FMI) to Tex Tech Industries WICHITA, Kan. , Jan. 13, 2025 /PRNewswire/ -- Today, Spirit AeroSystems Holdings, Inc. (NYSE: SPR) ("Spirit," "Spirit AeroSystems" or the "Company") announced the sale of Fiber Materials Inc ("FMI")…
prnewswire.com Spirit Announces Purchase Agreement with Tex Tech Industries for Intended Sale of Fiber Materials, Inc. (FMI) WICHITA, Kan. , Nov. 18, 2024 /PRNewswire/ -- Today, Spirit AeroSystems Holdings, Inc. (NYSE: SPR) ("Spirit," "Spirit AeroSystems" or the "Company") announces a purchase agreement to sell Fiber…
globenewswire.com Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop Foundation…
businesswire.com Foundation Medicine Announces Timing for First Quarter 2018 Financial
Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2018 will be released on Wednesday,…
businesswire.com Foundation Medicine Announces Timing for Fourth Quarter and Year-End
2017 Financial Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2017 will be released on…
businesswire.com FDA Approves Foundation Medicine’s FoundationOne CDx™, the First and
Only Comprehensive Genomic Profiling Test for All Solid Tumors
Incorporating Multiple Companion Diagnostics CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne CDx™, the company’s comprehensive…
businesswire.com Foundation Medicine Announces Timing for Third Quarter 2017 Financial
Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2017 will be released on…
businesswire.com Foundation Medicine Announces Timing for Second Quarter 2017
Financial Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2017 will be released on Tuesday,…
businesswire.com Foundation Medicine Announces Timing for First Quarter 2017 Financial
Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2017 will be released on Tuesday, May…
benzinga.com 20 Biggest Mid-Day Gainers For Wednesday 
businesswire.com Foundation Medicine Announces Timing for Fourth Quarter and Year-End
2016 Financial Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2016 will be released on…
businesswire.com Foundation Medicine Reports Preliminary 2016 Results CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine (NASDAQ:FMI) today announced preliminary unaudited total revenue of approximately $28.8 million in the fourth quarter of 2016 and approximately…
businesswire.com Foundation Medicine Announces Timing for Third Quarter 2016 Financial
Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2016, will be released on…
businesswire.com Foundation Medicine Announces Timing for Second Quarter 2016
Financial Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2016, will be released on Tuesday,…
businesswire.com Foundation Medicine Announces Timing for First Quarter 2016 Financial
Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2016, will be released on Tuesday, May…
businesswire.com Foundation Medicine Announces Timing for Fourth Quarter and Year-End
2015 Financial Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2015, will be released on…
businesswire.com Foundation Medicine Reports Preliminary 2015 Results and Provides
2016 Business Outlook, including Commercial Launch of its ctDNA Assay CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine (NASDAQ:FMI) today announced preliminary unaudited total revenue of approximately $26.1 million in the fourth quarter of 2015 and $93.2 million…
businesswire.com Foundation Medicine Announces Timing for Third Quarter 2015 Financial
Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2015, will be released on Tuesday,…
businesswire.com Foundation Medicine Announces Timing for Second Quarter 2015
Financial Results and Conference Call CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2015, will be released on Wednesday,…
benzinga.com The Best Biotech ETF Isn't Always The Biggest